# Pancreatic Cancer

Itraconazole has retrospective-combination relevance in **recurrent pancreatic cancer**, where standard treatment options are often limited.

### Overview

The main interest here is not standalone activity, but whether itraconazole can add useful pathway pressure when combined with chemotherapy.

### Key human data

* A retrospective study used **400 mg daily for four days, repeated every two weeks**, with chemotherapy
* Overall survival was reported as significantly improved compared with chemotherapy alone

### Practical interpretation

This is still an early and non-definitive signal, but it is strong enough to justify pancreatic cancer as a real page in the topic.

### References

Repurposing itraconazole for the treatment of cancer\
<https://pmc.ncbi.nlm.nih.gov/articles/PMC6769799/>

{% hint style="warning" %}
This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use.
{% endhint %}

{% hint style="info" %}
© 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text.
{% endhint %}


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/itraconazole-in-oncology/itraconazole-evidence-by-cancer-type/pancreatic-cancer.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.